Prometheus Phase II Data For Novel TL1A Inhibitor Impresses On Efficacy

 
• By Jessica Merrill
  
Bullseye
Prometheus hit the mark on a key Phase II trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D